Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7711518 | 0.86 | KMT2A (0.33) | MEN1KMT2A | |
| SCHEMBL28960083 | 0.83 | KMT2A (0.35) | MEN1KMT2A | |
| SCHEMBL8493070 | 0.74 | KMT2A (0.41) | MEN1KMT2A | |
| SCHEMBL10591414 | 0.73 | KMT2A (0.40) | MEN1KMT2A | |
| SCHEMBL7861908 | 0.73 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL4947041 | 0.69 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL4947035 | 0.68 | MEN1 (0.39) | MEN1KMT2A | |
| SCHEMBL23094077 | 0.68 | NOS1 (0.34) | KMT2A | |
| SCHEMBL28289841 | 0.68 | MEN1 (0.34) | MEN1KMT2A | |
| SCHEMBL8392334 | 0.67 | NPSR1 (0.43) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3457850-B1 | SYNERGISTIC COMBINATION OF BIOCIDES | ARXADA LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| US-20230247989-A1 | Synergistic Biocide Composition With a Polyglycerol Ester | ARCH UK BIOCIDES LTD (GB) | 2023-08-10 | — | — | US | disclosed |
| CN-115768262-A | Synergistic biocide composition with polyglycerol esters | 阿奇英国生物灭杀剂有限公司 | 2023-03-07 | — | — | CN | disclosed |
| EP-4120834-A1 | SYNERGISTIC BIOCIDE COMPOSITION WITH A POLYGLYCEROL ESTER | Arch UK Biocides Limited (GB) | 2023-01-25 | — | — | EP | disclosed |
| WO-2021214215-A1 | SYNERGISTIC BIOCIDE COMPOSITION WITH A POLYGLYCEROL ESTER | ARCH UK BIOCIDES LTD (GB) | 2021-10-28 | — | — | WO | disclosed |
| US-20200305435-A1 | SYNERGISTIC COMBINATION OF BIOCIDES | Arxada, LLC | 2020-10-01 | — | — | US | disclosed |
| CN-109640656-A | The synergistic combination of biocide | 伦萨公司 | 2019-04-16 | — | — | CN | disclosed |
| EP-3457850-A1 | SYNERGISTIC COMBINATION OF BIOCIDES | Lonza Inc. (US) | 2019-03-27 | — | — | EP | disclosed |
| WO-2017222965-A1 | SYNERGISTIC COMBINATION OF BIOCIDES | LONZA INC. (US) | 2017-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200305435-A1 | SYNERGISTIC COMBINATION OF BIOCIDES | POLR1C, BTD, UNG | MEN1 2400/4885KMT2A 2879/4885 |
| US-20230247989-A1 | Synergistic Biocide Composition With a Polyglycerol Ester | MGLL, PLD3, PHOSPHO1 | MEN1 2809/4885KMT2A 3659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.